✦ LIBER ✦

Efficacy and Safety of Triple Antiplatelet Therapy With and Without Concomitant Anticoagulation During Elective Percutaneous Coronary Intervention (the REMOVE Trial)

✍ Scribed by Rafael Valencia; Matthew J. Price; Neil Sawhney; Steve S. Lee; Garrett B. Wong; Raghava R. Gollapudi; Michelle Banares; Richard A. Schatz; Paul S. Teirstein

Book ID: 113444118
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 70 KB
Volume: 100
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2007.04.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE EFFICACY AND SAFETY OF TRIPLE ANTIPL

THE EFFICACY AND SAFETY OF TRIPLE ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION (PCI) IN J-CYPHER REGISTRY.

✍ Nakao, Tetsushi; Kimura, Takeshi; Morimoto, Takeshi; Shizuta, Satoshi; Tamura, T 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Triple antiplatelet therapy during percu

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival: Results from the do tirofiban and reoprogive similar efficacy outcome trial (TARGET)

✍ Albert W Chan; David J Moliterno; Peter B Berger; Gregg W Stone; Peter M DiBatti 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Triple antiplatelet therapy during percu

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including 1-year survival: results from the do tirofiban and ReoPro give similar efficacy outcome trial (TARGET)

✍ A.W Chan; D.J Moliterno; P.B Berger 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Comparison of Coronary Flow Reserve and

Comparison of Coronary Flow Reserve and Fractional Flow Reserve in Patients With Versus Without Diabetes Mellitus and Having Elective Percutaneous Coronary Intervention and Abciximab Therapy (from the PREDICT Trial)

✍ Annapoorna S. Kini; Michael C. Kim; Pedro R. Moreno; Prakash Krishnan; Oana C. I 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Safety and Efficacy of Bivalirudin With

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

A prospective, double-blind, randomized,

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

✍ Bin Nie; Wan-Jun Cheng; Yan-Fang Li; Zheng Cao; Qing Yang; Ying-Xin Zhao; Yong-H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views